11 04 2016

Metabomed completed an $18 million extension of Series A financing round

HFN advised MS Ventures, the corporate venture capital arm of Merck Serono, in its investment in an Israeli cancer metabolism company Metabomed. Metabomed has completed an $18 million extension of Series A financing round.


In addition to MS Ventures, investors include Boehringer Ingelheim Venture Fund, Pontifax Fund, and the Technion Research and Development Foundation. New investors, Pfizer and Arkin Holdings also joined the round. MS Ventures is the strategic, corporate venture arm of the biopharmaceutical division of Merck KGaA, Darmstadt, Germany. We invest globally in emerging biotechnology companies that develop products and or technologies that have the potential to significantly improve patient outcomes.
Along with the €100 million MS Ventures fund, our team also manages the €30 million Entrepreneur Partnership Program fund established to support the creation of spin-offs and the € 10 million Israel Bioincubator Fund, focused on pre-seed and seed opportunities coming out of Israel.
  Hi-Tech HFN' Partner Dan Sharot (Picture) led the transaction. Involved fees earner: Dan Sharot - Herzog Fox & Neeman;

LATEST ISSUE
Powered by Share Trading

POPULAR ARTICLES
LE FONTI AWARDS - AWARDING WORLDWIDE CORPORATE EXCELLENCE IN INNOVATION

09/05/2018

LE FONTI AWARDS - AWARDING WORLDWIDE CORPORATE EXCELLENCE IN INNOVATION Read about le

LE FONTI AWARDS 2018 CELEBRATES CORPORATE EXCELLENCES IN HONG KONG

29/03/2018

On March 23rd 2018, the world’s leading corporate stars reunited for a special

LE FONTI AWARDS 2017 CELEBRATES CORPORATE EXCELLENCES IN DUBAI

14/12/2017

On December 14th, 2017, the world’s leading corporate stars reunited for a spec

LE FONTI AWARDS 2017 CELEBRATE CORPORATE EXCELLENCES IN LONDON

23/10/2017

On October 20th, 2017, the world’s leading corporate stars reunited for a speci

Le Fonti IAIR Awards Take Hong Kong By Storm

21/03/2017

Hong Kong has become a city of bright expansion, culture, and futuristic innovation. Fr